Supporting first-pass accuracy is just the beginning
ADVIA 2120i Hematology System
Request informationThe challenging paradigm of manual slide reviews
While slide review rates can vary greatly between labs, studies show that on average, more than 20% of hematology samples trigger a manual scan or count.1,2 Reviews are critical to the release of accurate results, but high frequencies can potentially affect the laboratory in terms of both labor and cost efficiency,
leading to lower productivity (billed tests per full-time equivalent).3
Do more with less and chart a path to transform care delivery
Siemens Healthineers-equipped laboratories have a lower slide review rate than their peers, despite the fact that they perform more complete blood count tests on average.*
Keele University Independent Benchmarking Study, 2017
Optimize clinical operations with technology that can show you the difference
The ADVIA® 2120i Hematology System enables high-throughput CBC, differential, reticulocyte, body fluid, and multispecies testing. Reduce ambiguity, clearly distinguish normal from abnormal, and confidently release results with innovative analytical technologies that support first-pass accuracy.
White Blood Cells
Light scatter, cytochemical staining, and nuclear density on two independent channels provide accurate and specific flagging.
Red Blood Cells
Laser light scatter enables quantitative morphology flagging for sensitive and specific detection of minority cell populations.
Reticulocytes
The combination of laser light scatter and nucleic acid dye (oxadine 750) enables real-time assessment of erythropoietic activity.
Platelets
Analysis by Mie theory enables the discrimination of platelets and red cells above the typical cutoff of 30 fL.
Increase workforce productivity through advanced integration
From digital morphology and data management to total lab automation, Siemens Healthineers extended portfolio can reduce time-consuming manual touchpoints across hematology testing for labs of all sizes. Integration with the ADVIA 2120i system enables you to standardize operations from start to finish, raising the bar for quality and productivity in your lab.
CellaVision® Digital Morphology Systems
Streamline and standardize differential results by automating cell location and preclassification.
Atellica® Data Manager
Standardize testing, enhance quality control (QC), and streamline result management with our next-generation software.
Aptio® Automation
Increase efficiency and achieve consistent turnaround time with highly adaptable, multidisciplinary track configurations.
1
Kim, et al. Comparison study of the rates of manual peripheral blood smear review from 3 automated hematology analyzers, Unicel DxH 800, ADVIA 2120i, and XE 2100, using international consensus group guidelines. Arch Pathol Lab Med. 2012 Nov;136.
2
Novis D, Walsh M, Wilkinson D, St. Louis M, Ben-Ezra J. Arch Pathol Lab Med. 2006;130(5):596-601.
3
http://www.captodayonline.com/Archives/feature_stories/0405PeripheralBlud.html
ADVIA, Atellica, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. Aptio Automation is manufactured by Inpeco and is exclusively distributed by Siemens Healthcare Diagnostics Inc. Aptio is a trademark of Siemens Healthcare Diagnostics Inc. Inpeco is a trademark of Inpeco SA. Cellavision is a trademark of CellaVision AB. All other trademarks and brands are the property of their respective owners
The products/features mentioned here are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
*The results are based on the specific settings of these labs. Because there is no typical hospital or laboratory, and many variables exist (e.g., hospital size, samples mix, case mix, level of IT and/or automation adoption), there can be no guarantee that other customers will achieve the same results. Results in other cases may vary.